News

Matica Biotechnology and VaxDome, Inc. Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models

July 7, 2026

News

Matica Biotechnology Launches Integrated Korea IIT Platform Solution to Accelerate Global Advanced Therapy Development

June 18, 2026

News

Matica Biotechnology and Cirsium Biosciences Announce Adoption of Matica Open Access Platform to Accelerate Flexible AAV Manufacturing

June 16, 2026

News

Matica Biotechnology announces engagement by University Health Network (UHN) to supply cGMP Manufacturing of IL-10 Adenoviral Therapy for Lung Transplantation

June 9, 2026